Pancreatic Cancer Research Team
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Pancreatic Cancer Research Team sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Pancreatic Cancer Research Team: 5 sponsored US clinical trials, none currently recruiting.
Pancreatic Cancer Research Team sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stage IV Pancreatic Cancer, with 2 trials.
Upper-quartile sponsor footprint
Pancreatic Cancer Research Team sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA
NCT01893801
Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer
NCT01488552
Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer
NCT01298011
PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma
NCT00226005
Pancreatic Cancer Serum and DNA Repository
NCT00296114
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
How the Pancreatic Cancer Research Team early-phase archive is shaped
5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Stage IV Pancreatic Cancer (2 trials), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Pancreatic Cancer Research Team: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Pancreatic Cancer Research Team sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Pancreatic Cancer Research Team page
5 registered trials is a research-attention snapshot, not an endorsement of Pancreatic Cancer Research Team or any single study.
- None of Pancreatic Cancer Research Team's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Stage IV Pancreatic Cancer is the condition Pancreatic Cancer Research Team studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stage IV Pancreatic Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Pancreatic Cancer Research Team pipeline card: 5 registered trials from official public datasets.Report a data error.